BioVoice News September 2017 Issue 4 Volume 2 | Page 48

technology access to the poorest sections of our society at affordable prices, to the middle class, and to those who can afford higher-end technologies alike. Well-meaning policies, thereby, should factor in possible long- term implications, in order for them to be comprehensive. This will not just pave the way for universal health for all, providing impetus to the ‘Make in India’ vision while generating more employment opportunities. The pace of positive long-term changes unfolding in the country is quite promising. The terrific direction that our strategic foreign affairs policy has taken, apparent in the recent bilateral agreements signed with Israel gives hope for more nuanced and enabling domestic 48 BioVoiceNews | September 2017 policies, especially for the MedTech sector which is a fledgling and relatively nascent industry beseeching the right climate for investments and ease- of-doing business. Ensuring this alone will truly help medical device companies in India to prod their headquarters to ‘make in India’ and ‘make with India’, as PM Modi and PM Netanyahu suggested, for the world. MADHULIKA V. NARASIMHAN Madhulika V. Narasimhan is an independent communications consultant and a policy commentator with a passion for writing on public health, development and governance issues.